Abstract
Strong experimental data support the notion that excessive generation of reactive free radicals takes place in the ischemic area following a stroke episode and that these radicals are responsible for a substantial part of brain injury. However, the exact biochemical mechanisms underlying brain cell damage remain elusive, thus hindering the attempts for development of effective therapeutic strategies. In this presentation, the molecular mechanisms of tissue damage in relation to temporal and spatial generation of “reactive oxygen species” are considered. The mechanisms of oxidant-mediated brain damage are discussed and the role of “labile iron” in this process is evaluated. Although oxygen based oxidants are generated during all phases, their sources and intensities as well as their temporal and spatial generation differ considerably among different phases in stroke. Based on the above considerations, it is proposed that administration of appropriate “labile iron” chelating agents, preferentially prior to reperfusion, might improve the efficacy of any therapeutic strategy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abramov AY, Scorziello A, Duchen MR (2007) Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci 27:1129–1138
Allen CL, Bayraktutan U (2009) Oxidative stress and its role in the pathogenesis of ischemic stroke. Int J Stroke 4:461–470
Ambrosio G, Zweier JL, Flaherty JT (1991) The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion. J Mol Cell Cardiol 23:1359–1374
Antunes F, Cadenas E (2000) Estimation of H2O2 gradients across biomembranes. FEBS Lett 475:121–126
Azzi A, Davies KJA, Kelly F (2004) Free radical biology: terminology and critical thinking. FEBS Lett 558:3–6
Bailey DM, Robach P, Thomsen JJ, Lundby C (2006) Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke. Stroke 37:2453–2453
Barbouti A, Doulias PT, Zhu BZ, Frei B, Galaris D (2001) Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage. Free Radic Biol Med 31:490–498
Becker LB (2004) New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61:461–470
Becker LB, Vanden Hoek TL, Shao ZH, Li CQ, Schumacker PT (1999) Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol 277:H2240–H2246
Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD (2001) Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 32:553–560
Brennan AM, Suh SW, Won SJ, Narasimhan P, Kauppinen TM (2009) NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 12:857–863
Breuer W, Schvartsman M, Cabantchik ZI (2008) Intracellular labile iron. Int J Biochem Cell Biol 40:350–354
Carbonell T, Rama R (2007) Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr Med Chem 14:857–874
Carroll JE, Howard EF, Hess DC, Wakade CG, Chen Q, Chen C (1998) Nuclear factor-kB activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Mol Brain Res 56:186–191
Celic M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S et al (2004) Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A 99:2258–2263
Chan PH (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2–14
Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527–605
Chen H, Yoshioka H, Kim JS, Jung JE, Okami N (2011) Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antiox Redox Signal 14:1505–1517
Cherubini A, Ruggiero C, Polidori MC, Mecocci P (2005) Potential markers of oxidative stress in stroke. Free Radic Biol Med 39:841–852
Crack PJ, Taylor JM (2005) Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38:1433–1444
Cuzzocrea S, Riley DP, Caputi AP, Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53:135–159
Davalos A, Castillo J, Marrugat J, Fernandez-Real JM, Armengou A (2000) Body iron stores and early neurological deterioration in acute cerebral infarction. Neurology 54:1568–1574
Davies KJ (1999) The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48:41–47
Demougeot C, Van Hoecke M, Bertrand N, Pringent-Tessier A, Mossiat C (2004) Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2′-dipyridyl in the photothrombotic ischemic stroke model. J Pharmacol Exp Ther 311:1080–1087
Doulias P-T, Barbouti A, Galaris D, Ishiropoulos H (2001) SIN-1-induced DNA damage in isolated human peripheral blood lymphocytes as assessed by single cell gel electrophoresis (comet assay). Free Radic Biol Med 30:679–85
Doulias PT, Christoforidis S, Brunk UT, Galaris D (2003) Endosomal and lysosomal effects of desferrioxamine: protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest. Free Radic Biol Med 35:719–28
Endo H, Kamada H, Nito C, Nishi T, Chan PH (2006) Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J Neurosci 26:7974–7983
Epsztejn S, Kakhlon O, Glickstein H, Breuer W, Cabantchik I (1997) Fluorescence analysis of the labile iron pool of mammalian cells. Anal Biochem 248:31–40
Esposito BP, Epsztejn S, Breuer W, Cabantchik ZI (2002) A review of fluorescence methods for assessing labile iron in cells and biological fluids. Anal Biochem 304:1–18
Feigin VL, Lawes CMM, Bennett DA, Andrews CS (2003) Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2:43–53
Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J (1978) Free radicals in cerebral ischemia. Stroke 9:445–447
Galaris D, Pantopoulos K (2008) Oxidative stress and iron homeostasis: mechanistic and health aspects. Crit Rev Clin Lab Sci 45:1–23
Galaris D, Evangelou A (2002) The role of oxidative stress in mechanism of metal-induced carcinogenesis. Crit Rev Oncol Heamatol 42:93–103
Guzy RD, Hoyos B, Robin E, Chen H, Liu L et al (2005) Mitochondrial complex III is required hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1:401–408
Guzy RD, Schumacker PT (2006) Oxygen sensing my mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91:807–819
Halliwell B (2000) The antioxidant paradox. Lancet 355:1179–1180
Hentze MW, Muckenthaler MU, Galy B, Camaschella C (2010) Two to tango: regulation of mammalian iron metabolism. Cell 142:24–38
Huang J, Upadhyay U, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66:232–245
Huang J, Agus DB, Winfree CJ, Kiss S, Mack WJ et al (2001) Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cereboprotection in experimental stroke. Proc Natl Acad Sci U S A 98:11720–11724
Hurn PD, Koehler RG, Blizzard KK, Traystman RJ (1995) Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke 26:688–694
Jelkmann W (2010) Erythropoietin: back to basics. Blood 115:4151–4152
Joyeux-Faure M (2007) Cellular protection by erythropoietin: new therapeutic implications? J Pharmacol Exp Ther 323:759–762
Katavetin P, Tungsanga K, Eiam-Ong S, Nangaku M (2007) Antioxidative effects of erythropoietin. Kidney Int 107:S10–S15
Kurz T, Gustafson B, Brunk UT (2011) Cell sensitivity to oxidative stress is influenced by ferritin autophagy. Free Radic Biol Med 50:1647–1658
Lafon-Cazal M, Pletri S, Culcasi M, Bockaert J (1993) NMDA dependent superoxide production and neurotoxicity. Nature 364:535–537
Lapchak PA, Zivin JA (2003) Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low dose tissue plasminogen activator. Stroke 34:2013–2018
Leist M, Ghezzzi P, Grasso G, Bianchi R, Villa P, Fratelli M (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239–242
Lipscomb DC, Gorman LG, Traystman RJ, Hunt PD (1998) Low molecular weight iron in cerebral ischemic acidosis in vivo. Stroke 29:487–493
Liu S, Shi H, Liu W, Furuichi T, Timmins GS, Liu KJ (2004) Interstitial pO2 in ischemic penumbra and core are differentially affected following transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 24:343–349
Liu J, Narasimhan P, Yu F, Chan PH (2005) Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36:1264–1269
Ma Y, de Groot GH, Liu Z, Hider RC, Petrat F (2006) Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescence probes. Biochem J 395:49–55
Malhotra S, Savitz SI, Ocava L, Rosenbaum DM (2006) Ischemic preconditioning is mediated by erythropoietin through PI-3kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 83:19–27
Margaill I, Plotkine M, Lerouet D (2005) Antioxidant strategies in the treatment of stroke. Free Radic Biol Med 39:429–443
Mehta SH, Webb RC, Ergul A, Tawfik A, Dorrance AM (2004) Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke. Am J Physiol Regul Interg Comp Physiol 286:283–288
Methy D, Bertrand N, Prigent-Tessier A, Mossiat C, Stanimirovic D et al (2008) Beneficial effects of bipyridyl, a liposome iron chelator against focal cerebral ischemia: In vivo and in vitro evidence of protection of cerebral endothelial cells. Brain Res 1193:136–142
Millan M, Sobrino T, Castellanos M, Nombela F, Arenillas JF (2007) Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke. Stroke 38:90–95
Minnerup J, Heidrich J, Heidrich J, Roga lewski A, Schabitz WR, Wellmann J (2009) The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Stroke 40:3113–3120
Ollinger K, Brunk UT (1995) Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radic Biol Med 19:565–574
Pantopoulos K (2004) Iron metabolism and the IRE/IRP regulatory system: an update. Ann N Y Acad Sci 1012:1–13
Persson HL, Yu Z, Tirosh O, Eaton JW, Brunk UT (2003) Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Radic Biol Med 34:1295–1305
Prass K, Ruscher K, Karsch M, Isaev N, Megov D et al (2002) Desferoxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22:520–525
Rhee S-G (2006) H2O2, a necessary evil for cell signaling. Science 312:1882–1883
Rink C, Khanna S (2011) Significance of brain tissue oxygenation and arachidonic acid cascade in stroke. Antiox Redox Signal 14:1890–1903
Ruscher K, Freyer D, Karsch M, Isaev N, Megow D et al (2002) Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22:10291–10301
Sarti C, Rastenyte D, Cepaitis Z, Tuomiletho J (2000) International trends in mortality from stroke. Stroke 31:1588–1601
Selim MH, Ratan RR (2004) The role of iron neurotoxicity in ischemic stroke. Ageing Res 3:345–353
Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A et al (2007) NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357:562–571
Sies H (1985) Oxidative stress: introductory remarks. In: Sies H (ed) Oxidative stress. Academic, Orlando, FL, pp 1–7
Soloniuk DS, Perkins E, Wilson JR (1992) Use of allopurinol and deferoxamine in cellular protection during ischemia. Surg Neurol 38:110–113
Stone JA, Yang S (2006) Hydrogen peroxide: a signalling messenger. Antiox Redoc Signal 8:243–269
Tavling P, Lustenberger T, Kobayashi L, Inaba K, Barmparas G et al (2010) Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study. Ann Surg 251:1–4
Tenopoulou M, Doulias P-T, Barbouti A, Brunk U, Galaris D (2005) The role of compartmentalized redox-active iron on hydrogen peroxide-induced DNA damage and apoptosis. Biochem J 387:701–710
Tenopoulou M, Kurz T, Doulias P-T, Galaris D, Brunk U (2007) Does the calcein-AM method assay the total cellular “labile iron pool” or only a fraction of it? Biochem J 403:261–266
Togashi H, Shinzawa H, Matsuo T, Takeda Y, Takahashi T et al (2000) Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging. Free Radic Biol Med 28:846–853
Uchiyama A, Kim J-S, Kon K, Jaeschke H, Ikejima K et al (2008) Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury. Hepatology 48:1644–1654
Vaux EC, Metzen E, Yeates KM, Ratcliffe PJ (2001) Regulation of hypoxia-inducible factor is preserved in the absence of a functional mitochondrial respiratory chain. Blood 98:296–302
Veal EA, Day AM, Morgan BA (2007) Hydrogen peroxide sensing and signalling. Mol Cell 26:1–14
Wang Y, Zhang ZG, Rhodes K, Renzi M, Zhang RL et al (2007) Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br J Pharmacol 151:1377–1384
Weinreb O, Amit T, Mandel S, Kupershmidt L, Youdim MBH (2010) Neuroprotective multifactional iron chelators: from redox-sensitive process to novel therapeutic opportunities. Antiox Redox Signal 13:919–949
Wiese AG, Pacifici RE, Davies KJ (1995) Transient adaptation of oxidative stress in mammalian cells. Arch Biochem Biophys 318:231–240
Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP (1998) Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 53:613–625
Zhengquan Y, Persson H, Eaton J, Brunk U (2003) Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radic Biol Med 34:1243–1252
Zweier JL, Flaherty JT, Weisfeldt ML (1987) Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A 84:1404–1407
Acknowledgements
The authors would like to thank Drs. Panagiotis Korantzopoulos and Stilianos Kokkoris for critical reading of the manuscript and helpful comments.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Galaris, D., Kitsati, N., Pelidou, SH., Barbouti, A. (2012). Implication of Oxidative Stress and “Labile Iron” in the Molecular Mechanisms of Ischemic Stroke. In: Li, Y., Zhang, J. (eds) Metal Ion in Stroke. Springer Series in Translational Stroke Research. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9663-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9663-3_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9662-6
Online ISBN: 978-1-4419-9663-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)